Opioids in chronic non-cancer pain

被引:54
作者
Chan, Bob Kwok Bun [1 ]
Tam, Lee Ka [1 ]
Wat, Chun Yin [1 ]
Chung, Yu Fai [1 ]
Tsui, Siu Lun [1 ]
Cheung, Chi Wai [1 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Anaesthesiol, Hong Kong, Hong Kong, Peoples R China
关键词
analgesia; chronic; non-cancer pain; opioid; CHRONIC NONMALIGNANT PAIN; INDUCED BOWEL DYSFUNCTION; LOW-BACK-PAIN; MORPHINE-TOLERANCE; TRANSDERMAL FENTANYL; INDUCED HYPERALGESIA; DOWN-REGULATION; CLINICAL-TRIALS; NONMEDICAL USE; ORAL MORPHINE;
D O I
10.1517/14656566.2011.536335
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: The use of chronic opioid therapy for chronic non-cancer pain is growing and is now accepted as an effective treatment modality. Areas covered: Although there are guidelines and reviews for chronic opioid therapy for chronic non-cancer pain patients, physicians may still have concerns and be reluctant to prescribe strong opioids for chronic non-cancer pain. Common issues and concerns when prescribing opioid for chronic pain management are reviewed and discussed. The literature search was done using Medline with key words ''chronic non-cancer pain'', ''chronic opioid therapy'', ''effectiveness'', ''opioid tolerance'', ''opioid-induced hyperalgesia'', ''adverse effect'', ''opioid dependency'', ''addiction'', ''monitoring'', ''opioid contract'' and various combinations with these key words. Studies from 1990 -- 2010 have been included. This article helps readers to update, clarify and understand the common concerns when using opioid for chronic non-cancer pain. Clinical effectiveness and adverse effects with chronic opioid therapy, opioid tolerance and opioid-induced hyperalgesia, opioid dependency and addiction, monitoring during chronic opioid use, and opioid contact are discussed in detailed. Expert opinion: Not much strongly positive data supports the long-term use of opioids for pain relief, and the evidence for an improvement in functional activity is inconclusive. With careful selection of patients, meticulous prescription and monitoring protocol, chronic non-cancer pain patients who are likely to benefit from potent opioids should not be prevented from obtaining this treatment.
引用
收藏
页码:705 / 720
页数:16
相关论文
共 132 条
[1]  
Adams Edgar H, 2006, Pain Pract, V6, P254, DOI 10.1111/j.1533-2500.2006.00094.x
[2]   New approaches to pain control in patients with cancer [J].
Ahmedzai, S .
EUROPEAN JOURNAL OF CANCER, 1997, 33 :S8-S14
[3]   Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP) [J].
Akbik, Hammam ;
Butler, Stephen F. ;
Budman, Simon H. ;
Fernandez, Katherine ;
Katz, Nathaniel P. ;
Jamison, Robert N. .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2006, 32 (03) :287-293
[4]   Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients with chronic low back pain [J].
Allan, L ;
Richarz, U ;
Simpson, K ;
Slappendel, R .
SPINE, 2005, 30 (22) :2484-2490
[5]   Opioid-induced hyperalgesia - A qualitative systematic review [J].
Angst, MS ;
Clark, JD .
ANESTHESIOLOGY, 2006, 104 (03) :570-587
[6]  
[Anonymous], 2007, INT CLASSIFICATION D
[7]  
[Anonymous], MOD POL US CONTR SUB
[8]   Opioid contracts in chronic nonmalignant pain management: Objectives and uncertainties [J].
Arnold, RM ;
Han, PKJ ;
Seltzer, D .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (04) :292-296
[9]   Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrations [J].
Athanasos, P ;
Smith, CS ;
White, JM ;
Somogyi, AA ;
Bochner, F ;
Ling, W .
PAIN, 2006, 120 (03) :267-275
[10]  
Ballantyne Jane C, 2007, Pain Physician, V10, P479